Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription

Tumours and immortalized cells avoid telomere attrition by using either the ribonucleoprotein enzyme telomerase or a recombination-based alternative lengthening of telomeres (ALT) mechanism. Available evidence from mice suggests that the epigenetic state of the telomere may influence the mechanism of telomere maintenance, but this has not been directly tested in human cancer. Here we investigated cytosine methylation directly adjacent to the telomere as a marker of the telomere's epigenetic state in a panel of human cell lines. We find that while ALT cells show highly heterogeneous patterns of subtelomeric methylation, subtelomeric regions in telomerase-positive cells invariably show denser methylation than normal cells, being almost completely methylated. When compared to matched normal and ALT cells, telomerase-positive cells also exhibit reduced levels of the telomeric repeat-containing-RNA (TERRA), whose transcription originates in the subtelomere. Our results are consistent with the notion that TERRA may inhibit telomerase: the heavy cytosine methylation we observe in telomerase-positive cells may reflect selection for TERRA silencing in order to facilitate telomerase activity at the telomere. These data suggest that the epigenetic differences between telomerase-positive and ALT cells may underlie the mechanism of telomere maintenance in human tumorigenesis and highlight the broad reaching consequences of epigenetic dysregulation in cancer.

[1]  M. Fraga,et al.  Epigenetic regulation of telomeres in human cancer , 2008, Oncogene.

[2]  Y. Segev,et al.  Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. , 2008, Human molecular genetics.

[3]  M. Blasco,et al.  Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II , 2008, Nature Cell Biology.

[4]  C. Azzalin,et al.  Telomeric Repeat–Containing RNA and RNA Surveillance Factors at Mammalian Chromosome Ends , 2007, Science.

[5]  J. Blusztajn,et al.  Gestational Choline Deficiency Causes Global and Igf2 Gene DNA Hypermethylation by Up-regulation of Dnmt1 Expression* , 2007, Journal of Biological Chemistry.

[6]  M. Blasco,et al.  Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres , 2007, Nature Genetics.

[7]  S. Grewal,et al.  Heterochromatin revisited , 2007, Nature Reviews Genetics.

[8]  M. Fraga,et al.  DNA methyltransferases control telomere length and telomere recombination in mammalian cells , 2006, Nature Cell Biology.

[9]  M. Ehrlich,et al.  Cancer-linked DNA hypomethylation and its relationship to hypermethylation. , 2006, Current topics in microbiology and immunology.

[10]  J. Griffith,et al.  Telomeric DNA in ALT Cells Is Characterized by Free Telomeric Circles and Heterogeneous t-Loops , 2004, Molecular and Cellular Biology.

[11]  David I. K. Martin,et al.  Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue , 2004, International Journal of Colorectal Disease.

[12]  T. Jenuwein,et al.  Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases , 2004, Nature Genetics.

[13]  R. Reddel,et al.  Coexistence of Alternative Lengthening of Telomeres and Telomerase in hTERT-Transfected GM847 Cells , 2001, Molecular and Cellular Biology.

[14]  R. Reddel,et al.  Alternative Lengthening of Telomeres in Human Cells , 2001, Radiation research.

[15]  R. Reddel,et al.  Telomere maintenance by recombination in human cells , 2000, Nature Genetics.

[16]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[17]  A. Bird,et al.  Densely methylated sequences that are preferentially localized at telomere-proximal regions of human chromosomes. , 1999, Gene.

[18]  A. Wolffe,et al.  Epigenetics: regulation through repression. , 1999, Science.

[19]  R. Reddel,et al.  Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. , 1999, Cancer research.

[20]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[21]  E. Blackburn,et al.  The rate of telomere sequence loss in human leukocytes varies with age. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Reddel,et al.  Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines , 1997, Nature Medicine.

[23]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[24]  J. Shay,et al.  Telomerase activity in human germline and embryonic tissues and cells. , 1996, Developmental genetics.

[25]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[26]  J. Murnane,et al.  Telomere dynamics in an immortal human cell line. , 1994, The EMBO journal.

[27]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[28]  R. Myers,et al.  Structure and variability of human chromosome ends , 1990, Molecular and cellular biology.

[29]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[30]  L. Hayflick THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.